跳至主要内容
临床试验/NL-OMON22138
NL-OMON22138招募中不适用

The effect of bezafibrate on cholestatic pruritus

Academic Medical Center, Amsterdam0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age ≥ 18 years;
  • -Understanding of Dutch, English, German, Spanish or Italian language;

排除标准

  • -Concomitant guideline-recommended as well as experimental antipruritic therapy, e.g. rifampicin, opioid-receptor antagonists (naltrexon, naloxone), serotonin-reuptake inhibitors (sertraline), ondansetron, phenobarbital, propofol, lidocaine, dronabinol, butorphanol, internal or external biliary drainage, extracorporeal albumin dialysis, ultraviolet-B phototherapy;
  • NB. Topical menthol containing agents are allowed, as well as bile salt sequestrants (colesevelam, cholestyramin) as long as taken at least 4 hours before or after intake of the study medication. Incidental use of these agents should be noted by patients in the diary, structural use should be noted on the CRF (section co-medication);

研究者

发起方
Academic Medical Center, Amsterdam

相似试验